Horizon Investments LLC Trims Stock Position in The Clorox Company $CLX

Horizon Investments LLC lowered its holdings in shares of The Clorox Company (NYSE:CLX) by 94.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,367 shares of the company’s stock after selling 55,819 shares during the quarter. Horizon Investments LLC’s holdings in Clorox were worth $336,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. State Street Corp increased its holdings in Clorox by 3.5% in the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares in the last quarter. Invesco Ltd. increased its holdings in Clorox by 23.1% in the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after acquiring an additional 750,415 shares in the last quarter. Van ECK Associates Corp increased its holdings in Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after acquiring an additional 1,312,471 shares in the last quarter. Two Sigma Investments LP increased its holdings in Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Clorox by 4.8% in the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock worth $189,759,000 after acquiring an additional 70,783 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.1%

Shares of CLX opened at $92.04 on Friday. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $138.23. The company has a 50 day simple moving average of $106.03 and a two-hundred day simple moving average of $108.04. The firm has a market cap of $11.13 billion, a P/E ratio of 14.94, a price-to-earnings-growth ratio of 0.48 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm posted $1.45 EPS. The company’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts expect that The Clorox Company will post 5.63 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd were given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date was Wednesday, April 22nd. Clorox’s dividend payout ratio is currently 80.52%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Wells Fargo & Company reduced their target price on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Jefferies Financial Group reduced their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a report on Monday, May 4th. Finally, Barclays reduced their target price on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company. Based on data from MarketBeat, Clorox has an average rating of “Reduce” and an average price target of $104.00.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.63% of the company’s stock.

Key Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Unusual options activity showed strong bullish speculation, with traders buying 14,071 CLX call options on Friday, far above the typical daily volume. This may signal expectations for a rebound.
• Positive Sentiment: Several articles highlighted Clorox as a high-yield dividend stock, noting its roughly 5.7% yield and its potential to become a Dividend King in 2027 if it continues raising payouts.
• Positive Sentiment: A director reportedly bought about $429,100 worth of Clorox shares, which investors often view as a sign of insider confidence.
• Neutral Sentiment: Long-term performance commentary emphasized Clorox’s consistency as a consumer staples company, with steady dividends and resilience over the past decade, but without a clear new catalyst for near-term earnings. If You Had Invested $1,000 in Clorox a Decade Ago: A Prospective Dividend King’s Long-Term Payoff
• Negative Sentiment: Pomerantz LLP said it is investigating claims on behalf of Clorox investors, adding legal uncertainty that could weigh on the stock. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Clorox Company – CLX
• Negative Sentiment: Commentary noted that Clorox has fallen to an 11-year low, reflecting weaker investor confidence despite its dividend yield. Contrarian Take: This High-Yield Dividend Stock Is a Buy in May Despite Falling to an 11-Year Low

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.